(Q37570626)

21 August 2017

1 reference

title

Lipid modification in type 2 diabetes: the role of LDL and HDL. (English)

1 reference

21 August 2017

0 references

Bruno Vergès

1

1 reference

21 August 2017

24 July 2009

1 reference

Fundamental and Clinical Pharmacology

21 August 2017

1 reference

21 August 2017

23

1 reference

21 August 2017

6

1 reference

21 August 2017

681-685

1 reference

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

New insight into the pathophysiology of lipid abnormalities in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Postheparin Plasma Lipoprotein Lipase and Hepatic Lipase in Diabetes Mellitus: Relationship to Plasma Triglyceride Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Adiponectin is an important determinant of apoA-I catabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Non enzymatic glycation of apolipoprotein A-I. Effects on its self-association and lipid binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Reverse cholesterol transport in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

HDL cholesterol: physiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2009.00739.X

10.1111/J.1472-8206.2009.00739.X

21 January 2018

Identifiers

DOI

1 reference

release_qg7nfag3nvb57hygpkmh4kajxi

21 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qg7nfag3nvb57hygpkmh4kajxi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

19650852

1 reference

PubMed ID

19650852